Bellerophon Therapeutics ... (BLPH)
undefined
undefined%
At close: undefined
0.00
-100.00%
After-hours Dec 31, 1969, 07:00 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12
Net Income -19.83M -17.76M -24.73M -13.27M 2.81M -54.82M -23.81M -46.46M -59.67M -62.00M -46.23M
Depreciation & Amortization 65.00K 102.00K 147.00K 348.00K 362.00K 373.00K 400.00K 377.00K 388.00K 429.00K 85.00K
Stock-Based Compensation 786.00K 1.13M 1.63M 2.15M 2.96M 2.84M 2.76M 1.75M 1.84M 1.72M 1.45M
Other Working Capital 386.00K -200.00K -15.00K 245.00K 2.76M 4.57M 4.31M -642.00K -10.20M 2.47M 5.31M
Other Non-Cash Items -1K -600.00K 300.00K -2.01M -22.06M 30.51M 1.00M 45.00K - 149.00K 315.00K
Deferred Income Tax - - 327.00K - -2.81M -6.00K 34.00K - - - 2.84M
Change in Working Capital 1.21M -5.69M 2.44M -161.00K 3.25M 5.36M 2.40M -1.98M -13.12M 2.47M 5.31M
Operating Cash Flow -17.77M -22.82M -19.88M -12.94M -15.49M -15.74M -17.21M -46.26M -70.56M -57.23M -36.22M
Capital Expenditures - - - - - - -22.00K -458.00K - -727.00K -3.48M
Acquisitions - - - - - - - 458.00K - - -
Purchase of Investments - - - - - -5.98M - -22.76M - - -
Sales Maturities Of Investments - - - - 3.00M 8.56M 12.22M 4.91M - - -
Other Investing Acitivies - - - - - - - -458.00K - - -
Investing Cash Flow - - - - 3.00M 2.58M 12.20M -18.30M - -727.00K -3.48M
Debt Repayment - - - - - - - - - - -
Common Stock Repurchased - - - - -28.00K - - - -29.00K - -
Dividend Paid - - - - - - - - - - -
Other Financial Acitivies -40.00K - 2.87M -69.00K 194.00K 2.53M -128.00K 187.00K 87.41M 57.96M 39.70M
Financial Cash Flow -40.00K - 57.57M 6.17M 166.00K 27.78M 13.21M 54.01M 87.38M 57.96M 39.70M
Net Cash Flow -17.81M -22.82M 37.68M -6.77M -12.33M 14.62M 8.19M -10.55M 16.82M - -
Free Cash Flow -17.77M -22.82M -19.88M -12.94M -15.49M -15.74M -17.23M -46.72M -70.56M -57.96M -39.70M